[MYGN] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
06-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 59.71%
YoY- -419.23%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 177,800 160,800 154,600 195,100 216,800 194,000 196,500 -1.65%
PBT -52,100 -43,500 -55,700 -11,400 3,600 3,700 12,100 -
Tax -9,800 -35,900 -11,500 -3,100 1,000 -28,400 6,200 -
NP -42,300 -7,600 -44,200 -8,300 2,600 32,100 5,900 -
Tax Rate - - - - -27.78% 767.57% -51.24% -
Total Cost 220,100 168,400 198,800 203,400 214,200 161,900 190,600 2.42%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -23.79 -4.73 -28.59 -4.25 1.20 16.55 3.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.52 -0.10 -0.59 -0.11 0.04 0.46 0.09 -
EPS Diluted -0.52 -0.10 -0.59 -0.11 0.03 0.45 0.09 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.